- Home
- WNS vs SLNO Comparison
WNS vs SLNO Comparison
Compare WNS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNS
- SLNO
- Stock Information
- Founded
- WNS 1996
- SLNO 1999
- Country
- WNS India
- SLNO United States
- Employees
- WNS N/A
- SLNO N/A
- Industry
- WNS Business Services
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WNS Consumer Discretionary
- SLNO Health Care
- Exchange
- WNS Nasdaq
- SLNO Nasdaq
- Market Cap
- WNS 2.5B
- SLNO 3.8B
- IPO Year
- WNS N/A
- SLNO 2014
- Fundamental
- Price
- WNS $65.09
- SLNO $86.21
- Analyst Decision
- WNS Buy
- SLNO Strong Buy
- Analyst Count
- WNS 8
- SLNO 9
- Target Price
- WNS $63.00
- SLNO $103.33
- AVG Volume (30 Days)
- WNS 714.7K
- SLNO 1.1M
- Earning Date
- WNS 07-17-2025
- SLNO 08-06-2025
- Dividend Yield
- WNS N/A
- SLNO N/A
- EPS Growth
- WNS 24.08
- SLNO N/A
- EPS
- WNS 3.71
- SLNO N/A
- Revenue
- WNS $1,314,942,000.00
- SLNO N/A
- Revenue This Year
- WNS $5.56
- SLNO N/A
- Revenue Next Year
- WNS $9.37
- SLNO N/A
- P/E Ratio
- WNS $17.42
- SLNO N/A
- Revenue Growth
- WNS N/A
- SLNO N/A
- 52 Week Low
- WNS $42.62
- SLNO $39.41
- 52 Week High
- WNS $72.11
- SLNO $86.79
- Technical
- Relative Strength Index (RSI)
- WNS 68.58
- SLNO 66.86
- Support Level
- WNS $56.23
- SLNO $81.61
- Resistance Level
- WNS $59.07
- SLNO $86.79
- Average True Range (ATR)
- WNS 2.38
- SLNO 3.15
- MACD
- WNS 0.73
- SLNO 0.27
- Stochastic Oscillator
- WNS 91.97
- SLNO 94.55
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.